AIG
LENZ

American International Group’s LENZ Therapeutics LENZ Stock Holding History

American International Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,973
Closed -$44.1K – 2824
2024
Q1 		$44.1K Sell
1,973
-17
-0.9% -$353 ﹤0.01% 2812
2023
Q4 		$36.5K Sell
1,990
-8
-0.4% -$132 ﹤0.01% 2874
2023
Q3 		$34.7K Buy
1,998
+71
+4% +$1.24K ﹤0.01% 2909
2023
Q2 		$35.1K Buy
+1,927
New +$38.5K ﹤0.01% 2955
2022
Q2 		– Sell
-2,094
Closed -$75K – 3288
2022
Q1 		$75K Buy
2,094
+860
+70% +$53.8K ﹤0.01% 2698
2021
Q4 		$107K Sell
1,234
-36
-3% -$2.98K ﹤0.01% 2688
2021
Q3 		$146K Buy
+1,270
New +$188K ﹤0.01% 2613

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

American International Group's LENZ Position: Q2 2024 in Review

American International Group sold out of LENZ Therapeutics (LENZ) in Q2 2024, closing a stake of 1,973 shares — an estimated $44.1K sold.

American International Group first reported a position in LENZ in Q3 2021 and held it in 7 quarters. The position peaked at $146K in Q3 2021. 65 funds tracked by Wall St. Rank hold LENZ as of Q2 2024.

  • American International Group reported no remaining LENZ Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,973 LENZ Therapeutics shares in Q2 2024, an estimated $44.1K.
  • American International Group first reported a position in LENZ Therapeutics in Q3 2021 and held it in 7 quarters.
  • American International Group's LENZ Therapeutics position peaked at $146K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.